PALISADE BIO, INC.: 10-K filed 2014-03-10

Name: PALISADE BIO, INC.: 10-K filed 2014-03-10
Creator: PALISADE BIO, INC.

What PALISADE BIO, INC. reported in its annual report filed 2014-03-10 (fiscal FY 2013): 35 published measures, 116 facts as tagged in accession 0001144204-14-014279.

This filing

Form: 10-K (annual report)
Filed: 2014-03-10
Fiscal period: fiscal FY 2013
Accession: 0001144204-14-014279 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PALISADE BIO, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-12-31	19,413,536	USD
At 2012-12-31	8,750,079	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2013-12-31	10,995,337	USD
At 2012-12-31	1,777,446	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2013-12-31	8,418,199	USD
At 2012-12-31	6,972,633	USD
At 2011-12-31	1,659,818	USD
At 2010-12-31	7,854,350	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-12-31	16,846,052	USD
At 2012-12-31	7,443,773	USD
At 2011-12-31	2,352,013	USD
At 2010-12-31	9,261,233	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	-3,303,188	USD	92
2013-01-01 to 2013-12-31	-19,831,862	USD	365
2013-07-01 to 2013-09-30	-6,686,957	USD	92
2013-04-01 to 2013-06-30	-6,251,630	USD	91
2013-01-01 to 2013-03-31	-3,590,087	USD	90
2012-10-01 to 2012-12-31	-2,714,964	USD	92
2012-01-01 to 2012-12-31	-10,121,517	USD	366
2012-07-01 to 2012-09-30	-2,577,391	USD	92
2012-04-01 to 2012-06-30	-2,376,381	USD	91
2012-01-01 to 2012-03-31	-2,452,781	USD	91
2011-01-01 to 2011-12-31	-12,518,527	USD	365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	125,362	USD	365
2012-01-01 to 2012-12-31	39,220	USD	366
2011-01-01 to 2011-12-31	196,412	USD	365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	2,500	USD	92
2013-01-01 to 2013-12-31	110,000	USD	365
2013-07-01 to 2013-09-30	2,500	USD	92
2013-04-01 to 2013-06-30	2,500	USD	91
2013-01-01 to 2013-03-31	102,500	USD	90
2012-10-01 to 2012-12-31	2,500	USD	92
2012-01-01 to 2012-12-31	407,708	USD	366
2012-07-01 to 2012-09-30	170,833	USD	92
2012-04-01 to 2012-06-30	78,125	USD	91
2012-01-01 to 2012-03-31	156,250	USD	91
2011-01-01 to 2011-12-31	390,625	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2013-12-31	-128,426,037	USD
At 2012-12-31	-108,594,175	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2013-01-01 to 2013-12-31	USD	365
2012-01-01 to 2012-12-31	USD	366
2011-01-01 to 2011-12-31	USD	365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2013-12-31	230,971	USD
At 2012-12-31	230,397	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	2,331,401	USD	365
2012-01-01 to 2012-12-31	1,610,845	USD	366
2011-01-01 to 2011-12-31	3,333,099	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	-2,762,573	USD	92
2013-01-01 to 2013-12-31	-12,523,941	USD	365
2013-07-01 to 2013-09-30	-3,633,986	USD	92
2013-04-01 to 2013-06-30	-3,235,602	USD	91
2013-01-01 to 2013-03-31	-2,891,780	USD	90
2012-10-01 to 2012-12-31	-2,726,826	USD	92
2012-01-01 to 2012-12-31	-10,156,456	USD	366
2012-07-01 to 2012-09-30	-2,583,159	USD	92
2012-04-01 to 2012-06-30	-2,383,255	USD	91
2012-01-01 to 2012-03-31	-2,463,216	USD	91
2011-01-01 to 2011-12-31	-12,990,470	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-12-31	17,619,119	USD
At 2012-12-31	7,652,757	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	1,394,274	USD	365
2012-01-01 to 2012-12-31	2,699	USD	366
2011-01-01 to 2011-12-31	821	USD	365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-12-31	5,936,132	USD
At 2012-12-31	1,756,303	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2013-12-31	10,000	USD
At 2012-12-31	3,333	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	12,633,941	USD	365
2012-01-01 to 2012-12-31	10,564,164	USD	366
2011-01-01 to 2011-12-31	13,381,095	USD	365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	7,134,301	USD	365
2012-01-01 to 2012-12-31	6,105,984	USD	366
2011-01-01 to 2011-12-31	7,354,857	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-12-31	77,886,031	shares
At 2012-12-31	68,189,314	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2013-12-31	136,058,135	USD
At 2012-12-31	114,884,915	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2013-12-31	7,241	USD
At 2012-12-31	0	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2013-12-31	577,105	USD
At 2012-12-31	654,041	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2013-12-31	346,134	USD
At 2012-12-31	423,644	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2013-12-31	1,137,701	USD
At 2012-12-31	807,357	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2013-12-31	64,897	USD
At 2012-12-31	59,568	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2013-12-31	0	USD
At 2012-12-31	0	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	5,254,915	USD	365
2012-01-01 to 2012-12-31	4,247,037	USD	366
2011-01-01 to 2011-12-31	5,839,188	USD	365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	126,000	USD	365
2012-01-01 to 2012-12-31	101,000	USD	366
2011-01-01 to 2011-12-31	104,000	USD	365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	119,000	USD	365
2012-01-01 to 2012-12-31	110,000	USD	366
2011-01-01 to 2011-12-31	83,000	USD	365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	-7,307,921	USD	365
2012-01-01 to 2012-12-31	34,939	USD	366
2011-01-01 to 2011-12-31	471,943	USD	365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

Period	Unit	Days
2013-01-01 to 2013-12-31	USD	365
2012-01-01 to 2012-12-31	USD	366
2011-01-01 to 2011-12-31	USD	365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	-3,933,543	USD	365
2012-01-01 to 2012-12-31	-4,042,898	USD	366
2011-01-01 to 2011-12-31	-4,709,899	USD	365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Unit	Days
2013-01-01 to 2013-12-31	USD	365
2012-01-01 to 2012-12-31	USD	366
2011-01-01 to 2011-12-31	USD	365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2012-09-01 to 2012-09-30	7,000,000	USD	30
2012-08-01 to 2012-08-31	2,760,000	USD	31
2012-02-01 to 2012-02-28	5,200,000	USD	28

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2013-01-01 to 2013-12-31	6,667	USD	365
2012-01-01 to 2012-12-31	-231,042	USD	366
2011-01-01 to 2011-12-31	234,375	USD	365

Inspect the source

Entity: PALISADE BIO, INC. / CIK 0001357459
Captured: 2026-09-20T07:55:46.162Z
SEC response SHA-256: 1d4973c07aed8ad894103731546b55683b331acdd472b37e4b33a98a2f63a74c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001357459.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))